Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Pfizer's Ben Osborn is new president of ABPI

The UK country manager of Pfizer, Ben Osborn, has been confirmed as the new president of the Association of the British Pharmaceutical Industry (ABPI).

Pinder Sahota, general manager of Novo Nordisk, has been appointed as vice president.


Osborn will take over from outgoing president Haseeb Ahmad and will lead on overseeing the ABPI, the ABPI Board, and the ABPI’s Code of Practice, which is administered by the Prescription Medicines Code of Practice Authority (PMCPA).

His presidency will have three broad priorities - building a more resilient NHS post-pandemic by supporting the health service and the government to build back better from COVID-19, making sure that no patient is left behind.

Secondly priority will include putting life sciences at the heart of the UK’s future prosperity, helping to meet ABPI’s shared ambition of making the UK a science superpower.

Lastly it will focus on tackling global health challenges to find solutions for ongoing health emergencies like antimicrobial resistance (AMR) and to be ready for future pandemics.

Commenting on his new role, Osborn, said: “Our industry has made an incredible contribution in this pandemic. Like, working together with partners across the health and care space to research, develop, and deliver treatments and vaccines for Covid-19.

Message from new ABPI president Ben Osborn

"I want to use my presidency to learn from the successes of the past year and ensure the spirit of that mission-led approach to health is at the heart of everything we do; from adopting innovation to benefit patients across the country to bolstering the UK’s credentials as a life sciences superpower.”

Sahota, the new vice president of the ABPI, said: “It is an honour to serve the industry that discovers, develops and brings to patients medicines and innovation that are so needed. Our medicines support our vital NHS and enable healthy and productive communities to grow and thrive. At this time, it is critical we focus together to ensure health is at the heart of ‘levelling up’, for the benefit of all our communities.”

Welcoming the two new appointees, Richard Torbett, chief executive of the ABPI, said: “I am delighted to welcome both Ben and Pinder to their new roles and look forward to working with them on our shared goal of making the UK the best place in the world to research, develop and use new medicines and vaccines. The wealth of experience they both bring to the ABPI will be invaluable as we face down future challenges for our sector and work together to make the most of the opportunities to improve the lives of patients across the UK.”

The two appointments were made by the ABPI Board and took effect from May 1, 2021.

More For You

US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less